Round Table

Join us!

June 3

17:30 Panama / 16:30 Central America
Register here

Quantification of SARS-CoV-2 Anti-Spike antibodies:

Medical value in the current context of COVID-19

Agenda June 3 

17:30 Panama / 16:30 Central America
    Round Table
    Quantification of SARS-CoV-2 Anti-Spike antibodies
    17:30 - 19:30 Panama
    16:30 - 18:30 Central America
    Welcome & Introduction 

    Dr. Kharis Rebollón
    Roche's response to the COVID-19 pandemic
    17:40 -17:45
    María Paula De León
    Elecsys Anti SARS-CoV-2 S: The Next Frontier in SARS-CoV-2 Antibody Testing
    17:45 -18:00
    Dr. Soledad Ruíz
    Vaccination and seroprevalence studies: What role can SARS-CoV-2 antibody tests play?
    18:00 - 18:30
    Dr. Elizabeth Vinelli
    The value of quantification of anti-Spike antibodies to SARS-CoV-2 in convalescent plasma therapy
    18:30 - 19:00
    Closing
    2nd Webinar
    Lorem ipsum 08 July 2020
    15:00 - 16:15 CET
    Welcome and introduction
    Prof. James Januzzi
    Is a member of the Massachusetts General Hospital Cardiology Division. He is the Hutter Family Professor of Medicine at Harvard Medical School and is on faculty at the Harvard Clinical Research Institute
    13:30-13:45
    Dr. Raphael Twerenbold
    Is an interventional cardiologist and senior physician at the Clinic for Cardiology at the University Hospital Basel
    13:30-13:45
    Prof. Alexandre Mebazaa
    Is Professor of Anaesthesiology and Critical Care Medicine at the Hôpital Lariboisière, University Paris 7, France
    13:30-13:45
    Dr. Zhou Ning
    Associate Professor, Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
    13:30-13:45
    Q& session
    3rd Webinar
    Lorem ipsum 14 July 2020
    15:00 - 16:15 CET
    Welcome and introduction
    W. Conrad Liles
    MD, PhD, University of Washington, Seattle, US
    13:30-13:45
    Tobias Weinberger
    MD, Ludwig Maximilian University of Munich, Munich, Germany
    13:30-13:45
    Q& session
    4th Webinar
    Lorem ipsum 16 July 2020
    15:00 - 16:15 CET
    Welcome and introduction
    Prof. Anna Kajdy
    Head of Obstetrics Department, St. Sophie's Obstetrics and Gynecology Hospital, Warsaw, Poland
    13:30-13:45
    Prof. Liona Poon
    Clinical Professor, Obstetrics, CUHK, Hong Kong
    13:30-13:45
    Q& session

    #diagnostictests

    Topics to be discussed in the round table:

    - Roche Diagnostics response to the COVID-19 pandemic
    - Overview and Intended Use of Quantitative Spike Antibody Tests.
    - The role of SARS-CoV-2 anti-Spike antibodies in vaccine evaluation and seroprevalence studies
    - The value of quantification of anti-Spike antibodies to SARS-CoV-2 in convalescent plasma therapy


    ** This event is aimed at professionals related to the health industry. Free of charge.

    #Covid19Webinar

    08 July 2020 Webinar

    Coagulopathy in COVID-19: Which challenges do we face in the area of Coagulation.
    SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
    Systemic coagulation activation and thrombotic complications, such as venous thromboembolism, emerged as an important consideration in the management of patients.
    Experts around the globe are heavily seeking to understand the pathophysiological aspects and to provide guidance in therapy.
    In this webinar, which will focus entirely on topics related to the field of Coagulation,

    #Covid19Webinar

    14 July 2020 Webinar

    Coagulopathy in COVID-19: Which challenges do we face in the area of Coagulation.
    SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
    Systemic coagulation activation and thrombotic complications, such as venous thromboembolism, emerged as an important consideration in the management of patients.
    Experts around the globe are heavily seeking to understand the pathophysiological aspects and to provide guidance in therapy.
    In this webinar, which will focus entirely on topics related to the field of Coagulation,
    SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
    SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.

    #Covid19Webinar

    16 July 2020 Webinar

    Coagulopathy in COVID-19: Which challenges do we face in the area of Coagulation.
    SARS-CoV-2 has caused a pandemic with high mortality and is commonly complicated with coagulopathy, which is one of the most significant poor prognostic features of the disease.
    Systemic coagulation activation and thrombotic complications, such as venous thromboembolism, emerged as an important consideration in the management of patients.
    Experts around the globe are heavily seeking to understand the pathophysiological aspects and to provide guidance in therapy.
    In this webinar, which will focus entirely on topics related to the field of Coagulation,

    Invited panelists

    In this discussion, our panelists will discuss important details about the quantification of specific anti-Spike antibodies to SARS-CoV-2 in the context of vaccines, seroprevalence, and use in convalescent plasma.

    Dr. Soledad Reyes
    Dr. Elizabeth Vinelli
    Specialist in Clinical Laboratory with M.Sc. in Molecular Biology. She is currently Head of Service and Technical Director of the Laboratory and Blood Bank of the Clínica Alemana Temuco, Chile.
    Physician graduated from the Faculty of Medical Sciences at the National Autonomous University of Honduras. He holds an MBA and Certification in Transfusion Medicine from the Royal College of Physicians, Edinburgh. She was Director of the National Blood Program at the Honduran Red Cross; she is currently the Executive Director of the Teletón Foundation. He has participated in the Global Blood Safety Network through various institutions such as WHO, PAHO, AABB, and ISBT.

    Register here

    Please complete the following form to separate space in the event.
    (*) Mandatory